Effect of Atorvastatin Administration Before Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction.

Trial Profile

Effect of Atorvastatin Administration Before Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Dec 2011

At a glance

  • Drugs Atorvastatin (Primary)
  • Indications Myocardial infarction
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Dec 2011 Results published in the American Heart Journal.
    • 02 Mar 2011 Actual end date (Aug 2009) added as reported by ClinicalTrials.gov.
    • 21 Sep 2010 Primary endpoint 'Myocardial-infarct-size' has not been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top